Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. a leading biotech company in the hemp and cannabis industries. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ronanlevy/. Shlomi Raz.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JUNE 10, 2021

In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. The prevalence of cannabis-involved driving in California. Cannabis effects on driving skills. J Anal Toxicol. 2014;38(8):569–74. Drug Alcohol Depend.

Policy 59

Policy Safety Marijuana Data 59